CG Oncology, Inc.
NASDAQCG Oncology enters its November 12 earnings window with a notable split in its positioning signals: short sellers have been trimming exposure over the past month, yet options traders are the most defensively positioned they have been in weeks. The positioning picture is dominated by this divergence. Short interest has fallen to 13.2% of free float, down from around 16.8% a month…
Snapshot as of 18 Oct 2026
CG Oncology enters its November 12 earnings window with a notable split in its positioning signals: short sellers have been trimming exposure over the past month, yet options traders are the most defensively positioned…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CGON — free to start on ORTEX.
Sign up for free →Open CGON on ORTEX